Platelet-to-lymphocyte ratio (PLR) might have a predictive value in patients with chronic rhinosinusitis with nasal polyps in terms of treatment response to dupilumab, particularly PLR above 131.2.
FDA Approves First Nasal Spray for Chronic Rhinosinusitis Without Polyps
The FDA recently expanded the approval of the XHANCE fluticasone propionate nasal spray manufactured by Optinose for chronic rhinosinusitis to also include treatment of adults aged 18 and older without nasal polyps.
What Otolaryngologists Need to Know about Biologics and Allergic Rhinitis
Is There a Link Between Climate Change and Rhinosinusitis? Researchers Explore Possibilities
Is There a Role for Bedside Biopsy in the Evaluation of Acute Invasive Fungal Rhinosinusitis?
Is there a role for bedside biopsy in the evaluation of acute invasive fungal rhinosinusitis?
Oral Corticosteroid for Chronic Rhinosinusitis May Be Lower Risk Than Surgery
Here’s why the inclusion of oral corticosteroids as part of appropriate medical therapy for chronic rhinosinusitis may be the lower-risk strategy.
Sinus Surgery Is Still an Essential Part of Patient Care
Despite dips in the number performed, sinus surgery still plays an essential role in the treatment of invasive fungal rhinosinusitis.
Intranasal Corticosteroids Improve Asthma Symptoms in CRS
For patients with asthma and CRS, the addition of intranasal corticosteroids improved asthma symptoms as well as FEV1
New Rhinosinusitis Consensus Statement Offers Comprehensive Guidelines
New rhinosinusitis consensus statement sorts through a mountain of research to offer evidence-based pathology and therapy guidelines
Refractory Chronic Rhinosinusitis Carries High Productivity Cost
How much is lost in annual productivity costs for a patient with refractory chronic rhinosinusitis (RCRS), and what is the relationship between productivity costs and RCRS-specific characteristics?
- 1
- 2
- 3
- 4
- Next Page »